Sphingosine‑1‑phosphate induces islet β‑cell proliferation and decreases cell apoptosis in high‑fat diet/streptozotocin diabetic mice

He,Yizhi; Shi,Bingyin; Zhao,Xinrui; Sui,Jing

doi:10.3892/etm.2019.7999

Sphingosine‑1‑phosphate induces islet β‑cell proliferation and decreases cell apoptosis in high‑fat diet/streptozotocin diabetic mice

Authors:
- Yizhi He
- Bingyin Shi
- Xinrui Zhao
- Jing Sui
View Affiliations

Affiliations: Department of Endocrinology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China, Department of Immunology and Rheumatology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710004, P.R. China
Published online on: September 11, 2019 https://doi.org/10.3892/etm.2019.7999
Pages: 3415-3424
Copyright: © He et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Sphingosine‑1‑phosphate (S1P) has been reported to enhance the function of islet β‑cells, providing a potential therapeutic target for diabetes mellitus. In the present study, the effects of S1P on the proliferation and apoptosis of β‑cells in type 2 diabetic mice were investigated. The mice were administered intraperitoneal S1P solution daily at a dose of 20 µg/kg for three weeks. The intraperitoneal glucose tolerance test (IPGTT) and homeostatic model assessment of insulin resistance (HOMA‑IR) index determination were carried out. Immunohistochemical staining was used to detect the protein expression of insulin, antigen Ki‑67 and S1P receptor isoforms (S1PR1/S1PR2/S1PR3) in pancreatic islets. Compared with the diabetic control (DC) group, the IPGTT results and HOMA‑IR index in the S1P treatment group were decreased. The islets in the S1P group exhibited higher insulin immunostaining intensity than the DC group, as well as higher proliferation (P<0.05) and lower apoptosis rates (P<0.05). Positive staining for the S1P receptors S1PR1, S1PR2 and S1PR3 was observed in the cytoplasm and membrane of the islet cells. S1PR1 and S1PR2 proteins showed increased expression in the S1P and DC groups compared with the normal control group (P<0.01 and P<0.05, respectively), whereas no significant difference was observed in the expression of S1PR3 among these groups. In conclusion, extracellular S1P can induce islet β‑cell proliferation and decrease cell apoptosis in diabetic mice. S1P function may be mediated via S1PR1 and S1PR2; therefore, targeting S1P/S1PR signalling pathways may be a novel therapeutic strategy for diabetes mellitus.

View Figures

View References

1	Wang L, Gao P, Zhang M, Huang Z, Zhang D, Deng Q, Li Y, Zhao Z, Qin X, Jin D, et al: Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013. JAMA. 317:2515–2523. 2017. View Article : Google Scholar : PubMed/NCBI
2	Haass NK, Nassif N and McGowan EM: Switching the sphingolipid rheostat in the treatment of diabetes and cancer comorbidity from a problem to an advantage. Biomed Res Int. 2015:1651052015. View Article : Google Scholar : PubMed/NCBI
3	Billings LK and Florez JC: The genetics of type 2 diabetes: What have we learned from GWAS? Ann N Y Acad Sci. 1212:59–77. 2010. View Article : Google Scholar : PubMed/NCBI
4	Fayyaz S, Japtok L and Kleuser B: Divergent role of sphingosine 1-phosphate on insulin resistance. Cell Physiol Biochem. 34:134–147. 2014. View Article : Google Scholar : PubMed/NCBI
5	Silva VR, Micheletti TO, Pimentel GD, Katashima CK, Lenhare L, Morari J, Mendes MC, Razolli DS, Rocha GZ, de Souza CT, et al: Hypothalamic S1P/S1PR1 axis controls energy homeostasis. Nat Commun. 5:48592014. View Article : Google Scholar : PubMed/NCBI
6	Spiegel S and Milstien S: Functions of a new family of sphingosine-1-phosphate receptors. Biochim Biophys Acta. 1484:107–116. 2000. View Article : Google Scholar : PubMed/NCBI
7	Pulkoski-Gross MJ, Donaldson JC and Obeid LM: Sphingosine-1-phosphate metabolism: A structural perspective. Crit Rev Biochem Mol Biol. 50:298–313. 2015. View Article : Google Scholar : PubMed/NCBI
8	Maceyka M, Harikumar KB, Milstien S and Spiegel S: Sphingosine-1-phosphate signaling and its role in disease. Trends Cell Biol. 22:50–60. 2012. View Article : Google Scholar : PubMed/NCBI
9	Pyne S and Pyne NJ: New perspectives on the role of sphingosine 1-phosphate in cancer. Handb Exp Pharmacol. 55–71. 2013. View Article : Google Scholar : PubMed/NCBI
10	Cuvillier O, Pirianov G, Kleuser B, Vanek PG, Coso OA, Gutkind S and Spiegel S: Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature. 381:800–803. 1996. View Article : Google Scholar : PubMed/NCBI
11	Gómez-Muñoz A, Waggoner DW, O'Brien L and Brindley DN: Interaction of ceramides, sphingosine, and sphingosine 1-phosphate in regulating DNA synthesis and phospholipase D activity. J Biol Chem. 270:26318–26325. 1995. View Article : Google Scholar : PubMed/NCBI
12	Pyne S and Pyne NJ: The differential regulation of cyclic AMP by sphingomyelin-derived lipids and the modulation of sphingolipid-stimulated extracellular signal regulated kinase-2 in airway smooth muscle. Biochem J. 315:917–923. 1996. View Article : Google Scholar : PubMed/NCBI
13	Hatoum D, Haddadi N, Lin Y, Nassif NT and McGowan EM: Mammalian sphingosine kinase (SphK) isoenzymes and isoform expression: Challenges for SphK as an oncotarget. Oncotarget. 8:36898–36929. 2017. View Article : Google Scholar : PubMed/NCBI
14	Spiegel S and Milstien S: Sphingosine-1-phosphate: Signaling inside and out. FEBS Lett. 476:55–57. 2000. View Article : Google Scholar : PubMed/NCBI
15	Strub GM, Maceyka M, Hait NC, Milstien S and Spiegel S: Extracellular and intracellular actions of sphingosine-1-phosphate. Adv Exp Med Biol. 688:141–155. 2010. View Article : Google Scholar : PubMed/NCBI
16	Obinata H and Hla T: Sphingosine 1-phosphate in coagulation and inflammation. Semin Immunopathol. 34:73–91. 2012. View Article : Google Scholar : PubMed/NCBI
17	Blaho VA and Hla T: An update on the biology of sphingosine 1-phosphate receptors. J Lipid Res. 55:1596–1608. 2014. View Article : Google Scholar : PubMed/NCBI
18	Kihara Y, Maceyka M, Spiegel S and Chun J: Lysophospholipid receptor nomenclature review: IUPHAR Review 8. Br J Pharmacol. 171:3575–3594. 2014. View Article : Google Scholar : PubMed/NCBI
19	Wang F, Van Brocklyn JR, Hobson JP, Movafagh S, Zukowska-Grojec Z, Milstien S and Spiegel S: Sphingosine 1-phosphate stimulates cell migration through a G(i)-coupled cell surface receptor. Potential involvement in angiogenesis. J Biol Chem. 274:35343–35350. 1999. View Article : Google Scholar : PubMed/NCBI
20	Ishii I, Fukushima N, Ye X and Chun J: Lysophospholipid receptors: Signaling and biology. Annu Rev Biochem. 73:321–354. 2004. View Article : Google Scholar : PubMed/NCBI
21	Takuwa Y, Okamoto Y, Yoshioka K and Takuwa N: Sphingosine- 1-phosphate signaling in physiology and diseases. Biofactors. 38:329–337. 2012. View Article : Google Scholar : PubMed/NCBI
22	Völzke A, Koch A, Meyer ZHD, Huwiler A and Pfeilschifter J: Sphingosine 1-phosphate (S1P) induces COX-2 expression and PGE2 formation via S1P receptor 2 in renal mesangial cells. Biochim Biophys Acta. 1841:11–21. 2014. View Article : Google Scholar : PubMed/NCBI
23	Takuwa Y, Takuwa N and Sugimoto N: The Edg family G protein-coupled receptors for lysophospholipids: Their signaling properties and biological activities. J Biochem. 131:767–771. 2002. View Article : Google Scholar : PubMed/NCBI
24	Brinkmann V: Sphingosine 1-phosphate receptors in health and disease: Mechanistic insights from gene deletion studies and reverse pharmacology. Pharmacol Ther. 115:84–105. 2007. View Article : Google Scholar : PubMed/NCBI
25	Mandala S, Hajdu R, Bergstrom J, Quackenbush E, Xie J, Milligan J, Thornton R, Shei GJ, Card D, Keohane C, et al: Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science. 296:346–349. 2002. View Article : Google Scholar : PubMed/NCBI
26	Taha TA, Argraves KM and Obeid LM: Sphingosine-1-phosphate receptors: Receptor specificity versus functional redundancy. Biochim Biophys Acta. 1682:48–55. 2004. View Article : Google Scholar : PubMed/NCBI
27	Laychock SG, Tian Y and Sessanna SM: Endothelial differentiation gene receptors in pancreatic islets and INS-1 cells. Diabetes. 52:1986–1993. 2003. View Article : Google Scholar : PubMed/NCBI
28	Serafimidis I, Rodriguez-Aznar E, Lesche M, Yoshioka K, Takuwa Y, Dahl A, Pan D and Gavalas A: Pancreas lineage allocation and specification are regulated by sphingosine-1-phosphate signalling. PLoS Biol. 15:e20009492017. View Article : Google Scholar : PubMed/NCBI
29	Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF and Turner RC: Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28:412–419. 1985. View Article : Google Scholar : PubMed/NCBI
30	Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA and Butler PC: Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes. 52:102–110. 2003. View Article : Google Scholar : PubMed/NCBI
31	Ashcroft FM and Rorsman P: Diabetes mellitus and the β cell: The last ten years. Cell. 148:1160–1171. 2012. View Article : Google Scholar : PubMed/NCBI
32	Bonner-Weir S, Li WC, Ouziel-Yahalom L, Guo L, Weir GC and Sharma A: Beta-cell growth and regeneration: Replication is only part of the story. Diabetes. 59:2340–2348. 2010. View Article : Google Scholar : PubMed/NCBI
33	Mandrup-Poulsen T: beta-cell apoptosis: Stimuli and signaling. Diabetes. 50 (Suppl 1):S58–S63. 2001. View Article : Google Scholar : PubMed/NCBI
34	Kim RH, Takabe K, Milstien S and Spiegel S: Export and functions of sphingosine-1-phosphate. Biochim Biophys Acta. 1791:692–696. 2009. View Article : Google Scholar : PubMed/NCBI
35	Wei Q, Deng H, Cui H, Fang J, Zuo Z, Deng J, Li Y, Wang X and Zhao L: A mini review of fluoride-induced apoptotic pathways. Environ Sci Pollut Res Int. 25:33926–33935. 2018. View Article : Google Scholar : PubMed/NCBI
36	Guo H, Chen L, Cui H, Peng X, Fang J, Zuo Z, Deng J, Wang X and Wu B: Research advances on pathways of nickel-induced apoptosis. Int J Mol Sci. 17:E102015. View Article : Google Scholar : PubMed/NCBI
37	Qi Y, Chen J, Lay A, Don A, Vadas M and Xia P: Loss of sphingosine kinase 1 predisposes to the onset of diabetes via promoting pancreatic beta-cell death in diet-induced obese mice. FASEB J. 27:4294–4304. 2013. View Article : Google Scholar : PubMed/NCBI
38	Xia P, Wang L, Gamble JR and Vadas MA: Activation of sphingosine kinase by tumor necrosis factor-alpha inhibits apoptosis in human endothelial cells. J Biol Chem. 274:34499–34505. 1999. View Article : Google Scholar : PubMed/NCBI
39	Olivera A, Kohama T, Edsall L, Nava V, Cuvillier O, Poulton S and Spiegel S: Sphingosine kinase expression increases intracellular sphingosine-1-phosphate and promotes cell growth and survival. J Cell Biol. 147:545–558. 1999. View Article : Google Scholar : PubMed/NCBI
40	Sarkar S, Maceyka M, Hait NC, Paugh SW, Sankala H, Milstien S and Spiegel S: Sphingosine kinase 1 is required for migration, proliferation and survival of MCF-7 human breast cancer cells. FEBS Lett. 579:5313–5317. 2005. View Article : Google Scholar : PubMed/NCBI
41	Sukocheva O, Wadham C, Holmes A, Albanese N, Verrier E, Feng F, Bernal A, Derian CK, Ullrich A, Vadas MA and Xia P: Estrogen transactivates EGFR via the sphingosine 1-phosphate receptor Edg-3: The role of sphingosine kinase-1. J Cell Biol. 173:301–310. 2006. View Article : Google Scholar : PubMed/NCBI
42	Morales A, Lee H, Goñi FM, Kolesnick R and Fernandez-Checa JC: Sphingolipids and cell death. Apoptosis. 12:923–939. 2007. View Article : Google Scholar : PubMed/NCBI
43	Laychock SG, Sessanna SM, Lin MH and Mastrandrea LD: Sphingosine 1-phosphate affects cytokine-induced apoptosis in rat pancreatic islet beta-cells. Endocrinology. 147:4705–4712. 2006. View Article : Google Scholar : PubMed/NCBI
44	Shimizu H, Okajima F, Kimura T, Ohtani K, Tsuchiya T, Takahashi H, Kuwabara A, Tomura H, Sato K and Mori M: Sphingosine 1-phosphate stimulates insulin secretion in HIT-T 15 cells and mouse islets. Endocr J. 47:261–269. 2000. View Article : Google Scholar : PubMed/NCBI
45	Hasan NM, Longacre MJ, Stoker SW, Kendrick MA, Druckenbrod NR, Laychock SG, Mastrandrea LD and MacDonald MJ: Sphingosine kinase 1 knockdown reduces insulin synthesis and secretion in a rat insulinoma cell line. Arch Biochem Biophys. 518:23–30. 2012. View Article : Google Scholar : PubMed/NCBI
46	Ng ML, Wadham C and Sukocheva OA: The role of sphingolipid signalling in diabetesassociated pathologies (Review). Int J Mol Med. 39:243–252. 2017. View Article : Google Scholar : PubMed/NCBI
47	Lee SY, Lee HY, Song JH, Kim GT, Jeon S, Song YJ, Lee JS, Hur JH, Oh HH, Park SY, et al: Adipocyte-specific deficiency of de novo sphingolipid biosynthesis leads to lipodystrophy and insulin resistance. Diabetes. 66:2596–2609. 2017. View Article : Google Scholar : PubMed/NCBI
48	Kitada Y, Kajita K, Taguchi K, Mori I, Yamauchi M, Ikeda T, Kawashima M, Asano M, Kajita T, Ishizuka T, et al: Blockade of sphingosine 1-phosphate receptor 2 signaling attenuates high-fat diet-induced adipocyte hypertrophy and systemic glucose intolerance in mice. Endocrinology. 157:1839–1851. 2016. View Article : Google Scholar : PubMed/NCBI
49	Japtok L, Schmitz EI, Fayyaz S, Krämer S, Hsu LJ and Kleuser B: Sphingosine 1-phosphate counteracts insulin signaling in pancreatic beta-cells via the sphingosine 1-phosphate receptor subtype 2. FASEB J. 29:3357–3369. 2015. View Article : Google Scholar : PubMed/NCBI
50	Imasawa T, Koike K, Ishii I, Chun J and Yatomi Y: Blockade of sphingosine 1-phosphate receptor 2 signaling attenuates streptozotocin-induced apoptosis of pancreatic beta-cells. Biochem Biophys Res Commun. 392:207–211. 2010. View Article : Google Scholar : PubMed/NCBI